How severe is CVE-2018-5438?

CVE-2018-5438 has a CVSS 3.x base score of 6.3, rated medium severity. It is exploitable over local access with high attack complexity, requires low privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability none.

Is CVE-2018-5438 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (36th percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2018-5438?

CVE-2018-5438 affects Philips Intellispace Cardiovascular. See the affected-products list for the exact vulnerable versions.

How do I fix CVE-2018-5438?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.

When was CVE-2018-5438 published?

CVE-2018-5438 was published on 2018-03-20 and last updated on 2026-06-17.

CVE-2018-5438

CVE-2018-5438 is a medium-severity vulnerability in Philips Intellispace Cardiovascular with a CVSS 3.x base score of 6.3. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-613.

Key facts

Severity: Medium (CVSS 3.x base score 6.3)
CVSS v2: 3.3
EPSS exploit prediction: 0% (36th percentile)
Actively exploited: Not listed in CISA KEV
Weakness: CWE-613
Affected product: Philips Intellispace Cardiovascular
Published: 2018-03-20
Last modified: 2026-06-17

Description

Philips ISCV application prior to version 2.3.0 has an insufficient session expiration vulnerability where an attacker could reuse the session of a previously logged in user. This vulnerability exists when using ISCV together with an Electronic Medical Record (EMR) system, where ISCV is in KIOSK mode for multiple users and using Windows authentication. This may allow an attacker to gain unauthorized access to patient health information and potentially modify this information.

Frequently asked questions

What is CVE-2018-5438?: Philips ISCV application prior to version 2.3.0 has an insufficient session expiration vulnerability where an attacker could reuse the session of a previously logged in user. This vulnerability exists when using ISCV together with an Electronic Medical Record (EMR) system, where ISCV is in KIOSK mode for multiple users and using Windows authentication. This may allow an attacker to gain unauthorized access to patient health information and potentially modify this information.
How severe is CVE-2018-5438?: CVE-2018-5438 has a CVSS 3.x base score of 6.3, rated medium severity. It is exploitable over local access with high attack complexity, requires low privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability none.
Is CVE-2018-5438 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (36th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2018-5438?: CVE-2018-5438 affects Philips Intellispace Cardiovascular. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2018-5438?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
When was CVE-2018-5438 published?: CVE-2018-5438 was published on 2018-03-20 and last updated on 2026-06-17.

References

Affected products (1)

cpe:2.3:a:philips:intellispace_cardiovascular:*:*:*:*:*:*:*:*

More vulnerabilities in Philips Intellispace Cardiovascular

CVE-2018-14787 — High (CVSS 7.8): In Philips' IntelliSpace Cardiovascular (ISCV) products (ISCV Version 2.x or prior and Xcelera Version 4.1 or prior),…
CVE-2017-14111 — High (CVSS 7.2): The workstation logging function in Philips IntelliSpace Cardiovascular (ISCV) 2.3.0 and earlier and Xcelera R4.1L1 and…
CVE-2018-14789 — Medium (CVSS 6.7): In Philips' IntelliSpace Cardiovascular (ISCV) products (ISCV Version 3.1 or prior and Xcelera Version 4.1 or prior),…

All CVEs affecting Philips Intellispace Cardiovascular →

Other CWE-613 (Insufficient Session Expiration) vulnerabilities

CVE-2024-8888 — Critical (CVSS 10.0): An attacker with access to the network where CIRCUTOR Q-SMT is located in its firmware version 1.0.4, could steal the…
CVE-2026-46455 — Critical (CVSS 9.8): Insufficient Session Expiration vulnerability in Apache Camel Keycloak Component. The camel-keycloak security helper…
CVE-2026-21622 — Critical (CVSS 9.8): Insufficient Session Expiration vulnerability in hexpm hexpm/hexpm ('Elixir.Hexpm.Accounts.PasswordReset' module)…
CVE-2025-59786 — Critical (CVSS 9.8): 2N Access Commander version 3.4.2 and prior improperly invalidates session tokens, allowing multiple session cookies to…
CVE-2026-26342 — Critical (CVSS 9.8): Tattile Smart+, Vega, and Basic device families firmware versions 1.181.5 and prior implement an authentication token…
CVE-2026-1435 — Critical (CVSS 9.8): Not properly invalidated session vulnerability in Graylog Web Interface, version 2.2.3, due to incorrect management of…

Browse all CWE-613 (Insufficient Session Expiration) vulnerabilities →